Introduction: Renal Collecting Duct Cell Carcinoma (RCDCC) is a distinctive and aggressive form of Renal Cell Carcinoma (RCC). To date, there is no defined therapeutic strategy, and the evidence for Immunotherapy (IT) is very limited. The latest advances in molecular biology are aimed at clarifying therapeutic targets to guide therapeutics in this orphan tumor.
No takes yet. Share an insight, caveat, or question.
Marta Martínez Cutillas (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: